-
721
The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation
Published 2022-12-01“…We release a single-center longitudinal GBM MRI dataset with expert ratings of selected follow-up studies according to the response assessment in neuro-oncology criteria (RANO). The expert rating includes details about the rationale of the ratings. …”
Get full text
Article -
722
Medical and Nonmedical Information during Multidisciplinary Team Meetings in Cancer Care
Published 2021-02-01“…Data were collected from 336 case discussions in three MDTs for neuro-oncology, sarcoma and hepato-biliary cancer. Results: Information on physical status was presented in 48.2% of the case discussions, psychological status in 8.9% and comorbidity in 48.5% of the cases. …”
Get full text
Article -
723
-
724
-
725
-
726
Assessment of the clinical effectiveness and safety of immune checkpoint inhibitors for glioblastoma: A systematic review
Published 2023-12-01“…A total of 10 suitable articles, which encompass 168 patients (164 recurrent and 4 newly-diagnosed GBM), are taken into account. 3 studies assessed the OS, 7 studies assessed the PFS and/or response assessment in neuro-oncology (RANO) criteria and 8 studies assessed the safety, tolerability and/or adverse events. …”
Get full text
Article -
727
Oculomotor nerve palsy in neurofibromatosis type 2
Published 2022-11-01“…The patient was referred for specific treatment to the neuro-oncology unit. The case is distinct as the patient presented with a parasellar meningioma leading to third nerve palsy besides bilateral vestibular schwannomas. …”
Get full text
Article -
728
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Published 2022-01-01“…Adult medulloblastoma, in particular, is considered a rarer “orphan” entity in neuro-oncology practice because while treatments have progressively evolved for the pediatric population, no practice-changing prospective, randomized clinical trials have been performed in adults. …”
Get full text
Article -
729
PERFIL EPIDEMIOLÓGICO Y QUIRÚRGICO DE PACIENTES NEURO-ONCOLÓGICOS SOMETIDOS A CIRUGÍAS NEUROLÓGICAS
Published 2021-02-01“…Objective: to investigate the sociodemographic and surgical profile of neuro-oncology patients subjected to neurological surgeries. …”
Get full text
Article -
730
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
Published 2023-07-01Get full text
Article -
731
RETRACTED: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis
Published 2023-02-01“…Efficacy was evaluated according to the Response Assessment in Neuro-Oncology (RANO) criteria, and the main study endpoints were PFS at 6 months and overall survival (OS) at 1 year.ResultsAfter the follow-up, until May 2022, 13 patients survived and 13 patients died, with a median follow-up time of 25.6 months. …”
Get full text
Article -
732
-
733
-
734
-
735
-
736
Localization of Vestibular Cortex Using Electrical Cortical Stimulation: A Systematic Literature Review
Published 2024-01-01Get full text
Article -
737
-
738
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
Published 2021-03-01“…Unfortunately, these clinical successes have not been replicated in the neuro-oncology field so far. This review summarizes the status of ICI investigation in high-grade gliomas, critically presenting the available data from preclinical models and clinical trials. …”
Get full text
Article -
739
-
740
Prognostic factors and Doxorubicin involved in malignant progression of meningioma
Published 2023-04-01Get full text
Article